NFKB1 and myeloid sarcoma: As a central mediator of inflammation, NF-κB activity causes inappropriate inflammatory responses in rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis (MS) and atherosclerosis [12,13].